|
Delayed
NSE India S.E.
09:15:02 22/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1,736.20 INR | -0.51% |
|
-0.07% | +1.48% |
| Market Cap | 4,18700Cr 4.44TCr 3.95TCr 3.66TCr 3.31TCr 6.24TCr 6.32TCr 44TCr 17TCr 2,20100Cr 17TCr 16TCr 7,01300Cr | P/E 2027 * |
32.4x | P/E 2028 * | 27.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3,90200Cr 4.14TCr 3.68TCr 3.41TCr 3.09TCr 5.82TCr 5.89TCr 41TCr 16TCr 2,05100Cr 16TCr 15TCr 6,53600Cr | EV / Sales 2027 * |
5.99x | EV / Sales 2028 * | 5.27x |
| Free-Float |
44.39% | Yield 2027 * |
0.98% | Yield 2028 * | 1.14% |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUNPHARMA | Delayed | |
Bombay S.E.
| SUNPHARMA | Delayed |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | +0.12% | ||
| 1 week | -0.07% | ||
| Current month | -3.94% | ||
| 1 month | -6.62% | ||
| 3 months | -11.05% | ||
| 6 months | +4.80% | ||
| Current year | +1.48% |
| 1 week | 1,721.1 |  | 1,768.9 |
| 1 month | 1,721.1 | | 1,880 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,583.7 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 01/09/2025 | |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 71 | 21/05/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.12% | -0.07% | +3.23% | +52.78% | 4.41TCr | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,14400Cr | |
| -0.61% | +1.52% | +34.34% | +68.48% | 63TCr | |
| -1.48% | +0.47% | +23.08% | +94.76% | 51TCr | |
| +0.54% | +5.69% | +39.60% | +64.02% | 38TCr | |
| +1.07% | +1.70% | +71.06% | +45.98% | 37TCr | |
| +0.30% | +3.44% | +21.35% | +49.62% | 29TCr | |
| -0.03% | +2.55% | +1.12% | +20.94% | 26TCr | |
| -0.14% | +2.87% | +45.56% | +57.22% | 24TCr | |
| -1.88% | +0.02% | +23.77% | +97.39% | 19TCr | |
| Average | -0.02% | +3.32% | +32.20% | +66.86% | 40.52TCr | |
| Weighted average by Cap. | +0.33% | +4.11% | +40.40% | +79.27% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 65TCr 689.98Cr 614.84Cr 569.24Cr 515.15Cr 970.55Cr 982.05Cr 6.83TCr 2.68TCr 34TCr 2.59TCr 2.53TCr 1,09100Cr | 73TCr 773.52Cr 689.28Cr 638.16Cr 577.52Cr 1.09TCr 1.1TCr 7.65TCr 3TCr 38TCr 2.9TCr 2.84TCr 1,22300Cr |
| Net income | 13TCr 136.7Cr 121.81Cr 112.78Cr 102.06Cr 192.28Cr 194.56Cr 1.35TCr 530.56Cr 6.78TCr 512.79Cr 502.11Cr 22TCr | 15TCr 163.76Cr 145.93Cr 135.11Cr 122.27Cr 230.35Cr 233.08Cr 1.62TCr 635.62Cr 8.12TCr 614.33Cr 601.54Cr 26TCr |
| Net Debt | -28TCr -301.76Cr -268.9Cr -248.96Cr -225.3Cr -424.47Cr -429.5Cr -2.98TCr -1.17TCr -15TCr -1.13TCr -1.11TCr -48TCr | -34TCr -361.44Cr -322.08Cr -298.19Cr -269.86Cr -508.42Cr -514.44Cr -3.58TCr -1.4TCr -18TCr -1.36TCr -1.33TCr -57TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | ₹1,736.20 | -0.51% | 1,946 |
| 21/26/21 | ₹1,745.10 | +0.12% | 23,16,342 |
| 19/26/19 | ₹1,743.00 | -0.90% | 8,29,445 |
| 16/26/16 | ₹1,758.80 | -0.29% | 15,22,459 |
| 15/26/15 | ₹1,764.00 | +1.01% | 13,76,380 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
